USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
      Featured
      Our Next Event
      Register for LSI USA ‘26
      500+ Investors & Strategics
      See LSI USA '26 Attendee List
      Events Overview
      • Our Summits
      • Who Attends
      • Why Present
      Upcoming Summits
      • LSI USA ‘26
      • LSI Asia ‘26
      • LSI Europe '26
      Past Summits
      • LSI USA ‘25
      • LSI Asia ‘25
      • LSI Europe ‘25
      • Archives
  • Insights
      Featured
      Just Launched
      Compass AI
      New Report
      Emerging Innovators Report
      Compass Al
      Emerging Innovators Report
      Market Data
      Custom Research
  • Magazine
      Featured
      February Edition
      Explore Latest Editions
      The Lens Magazine
      Start Your Subscription
      Magazine
      • The Lens Magazine
      • Explore the Newest Edition
      • Read Free Articles
  • Resources
      Featured
      Released Weekly
      The LSI Alumni Weekly Recap
      Just Released
      2025 LSI Alumni Funding Report
      Resources
      • Research Desk
      • Testimonials
      • Video Library
      • Photo Gallery
  • Company
      Featured
      Our Next Event
      Register for LSI USA '26
      Just Launched
      Compass AI
      Company
      • About Us
      • Our Team
      • Press
  • Contact Us
Contact Us
USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
  • Insights
  • Magazine
  • Resources
  • Company
Events Overview
  • Our Summits
  • Who Attends
  • Why Present
Upcoming Summits
  • LSI USA ‘26
  • LSI Asia ‘26
  • LSI Europe ‘26
Past Summits
  • LSI USA ‘25
  • LSI Asia ‘25
  • LSI Europe ‘25
  • Archives
Featured
Our Next Event
Register for LSI USA '26
350+ Investors & Strategics
See LSI USA '26 Attendee List
Compass Al
Emerging Innovators Report
Market Data
Custom Research
Featured
Just Launched
Compass AI
New Report
Emerging Innovators Report
Magazine
The Lens Magazine
Explore the Newest Edition
Read Free Articles
Featured
February Edition
Explore Latest Editions
The Lens Magazine
Start Your Subscription
Resources
Research Desk
Testimonials
Video Library
Photo Gallery
Featured
Released Weekly
The LSI Alumni Weekly Recap
Just Released
2025 LSI Alumni Funding Report
Company
About Us
Our Team
Press
Featured
Our Next Event
Register for LSI USA '26
Just Launched
Compass AI
Join our Next Event
LSI USA ‘26, March 16-20, 2026
Waldorf Astoria, Monarch Beach
Register Today
Compass AI
The medtech-specific AI
research platform by LSI
Demo Compass AI
The Lens Magazine
The Lens Medtech
Magazine is LSI's most
curated industry coverage.
  1. Video Library
  2. Stay Adaptable and Scalable at Every Size — Growing from Five Employees to Hundreds | LSI USA '25

Stay Adaptable and Scalable at Every Size — Growing from Five Employees to Hundreds | LSI USA '25

Join Ed Muzio (Group Harmonics), Susan Insley (NextNav), and Jeff Pompeo (Caretaker Medical) as they discuss strategies for maintaining adaptability and scalability, essential for successfully growing your team from a startup of five to hundreds of employees.
Share social-facebook social-x social-linkedin
View Video Transcript
lsi logo
Contact Us

Upcoming Events

LSI USA ‘26
LSI USA ‘26
March 16-20, 2026
Dana Point, CA
LSI ASIA ‘26
LSI ASIA ‘26
June 30 - July 2, 2026
Singapore
LSI EUROPE ‘26
LSI EUROPE ‘26
Sept 28 - Oct 1, 2026
Barcelona

More From LSI

  • Attend an Event
  • Sponsor an Event
  • Compass, by LSI
  • The Lens, Magazine by LSI

Resources

  • Research Desk
  • Photo Gallery
  • Video Library
  • Testimonials
  • About Us

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy

Request Info
close
STEP 1
close-icon
The Lens - Complimentary Issue
close
close

Subscription Includes

Request Info

Global Medtech Market Analysis & Projections (MAP), 2021-2031
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf report

The Global Medtech Market Analysis and Projections (MAP) provides global market forecasts (2021 – ’31), share-by-supplier data, and analyst insights on 23 major device markets (e.g., Cardiovascular, Orthopedics, Neurovascular, In-Vitro Diagnostics) and 200+ technology subsegments. Understand major market trends and projections across the medtech industry with what medtech strategics and consulting firms have referred to as their “gold standard” for device market sizing data.

Global Surgical Procedure Volumes Dashboard, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Global Surgical Procedure Volumes database is the single source of truth for understanding diagnostic and therapeutic procedure volumes on a global scale. With coverage on 37 countries, including the United States, Europe’s Big Five, China, India, Japan and more for 12 major procedure markets (Cardio, Ortho, General Surgery, Radiosurgery, Neuro, OB/GYN and more), this fully interactive database is designed to facilitate one-to-one analyses of procedures, countries, and regions. Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

United States Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United States Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United States. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Aesthetics, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Aesthetics Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Aesthetics Procedures Database covers major aesthetic procedures, including: Biopsies, Punch Biopsies, Shave Biopsies, Incisional Biopsies, Lesion Removal Procedures, Curettage, electrocautery, and electrocoagulation lesion destruction, Photodestruction, Cryotherapy-based lesion destruction, Lesion Removal Procedures: Traditional and Other, Abdominoplasty, Blepharoplasty, Breast Augmentation, Breast Lift, Breast Reduction, Buttock Augmentation, Buttock Lift, Cheek Implants, Chin Augmentation, Facelift, Forehead Lift, Gynecomastia Treatment, Hair Transplantation, Lip Augmentation, Liposuction, Lower Body Lift, Otoplasty, Rhinoplasty, Thigh Lift, Upper Arm Lift, Vaginal Rejuvenation, Surgeries for Cleft Palate and Lip, Surgeries for Burn Injuries.

Cardio, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Cardiothoracic and Interventional Cardiology Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Cardiothoracic and Interventional Cardiology Procedures Database covers major cardiothoracic and interventional cardiology procedures, including: CABG Surgeries Off-Pump CABG, On-Pump CABG, Valve Procedures Aortic Valve Replacements, Mitral Valve Replacements, MV Repairs, AV Repairs, PV Replacements, PV Repairs, TV Operations, Percutaneous Valvuloplasties, Percutaneous Valve Replacements, CHD Surgeries Ventricular Septal Defect Closures, Patent Ductus Arteriosus Repairs, Atrial Septal Defect Closures, Repair of Tetralogy of Fallot, Arterial Shunts Surgeries, Atrioventricular Septal Defect Repairs, Transposition of Great Artery Procedures, Anomalous Pulmonary Venous Return Repairs, Other Congenital Heart Disease Surgeries, Other Cardiothoracic Surgeries Aortic Aneurysm Procedures, Other Cardiothoracic Surgeries, Diagnostic and Therapeutic Catheterizations, Stand-Alone Diagnostic Cardiac Catheterizations, Percutaneous Coronary Interventions, Coronary Interventions Radial Approach, Coronary Interventions Femoral Approach, Heart Rhythm Procedures Conventional Pacemaker Procedures, ICD Procedures, Cardiac Resynchronization Device Procedures, Combined Defib/Resynch Device Procedures, Cardiac Ablations.

ENT, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ear, Nose, and Throat Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ear, Nose, and Throat Surgical Procedures Database covers major ear, nose, and throat procedures, including: Tonsillectomies, Operations on the Ear, FESS, Tracheostomies, Thyroidectomies & Parathyroidectomies, Stand-Alone Adenoidectomies, Tongue Operations, Laryngeal Operations, Pharyngeal Operations, Radical Neck Dissection.

General, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The General Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The General Surgeries Procedures Database covers major general surgical procedures, including: Cholecystectomies Laparoscopic Cholecystectomies, Open Cholecystectomies, Appendectomies, Laparoscopic Appendectomies, Open Appendectomies, Herniorrhaphies Laparoscopic Herniorrhaphies, Open Herniorrhaphies, Bariatric Surgeries Laparoscopic Bariatric, Open Bariatric, Selected Other Endoscopic General & Colorectal Procedures Esophageal (Other Endoscopic), Stomach & Intestinal (Other Endoscopic), Colorectal (Other Endoscopic), Liver (Other Endoscopic), Gallbladder & Biliary (Other Endoscopic), Pancreatic (Other Endoscopic), Other (Other Endoscopic), Other Surgeries Esophageal (Other General, non-Endoscopic), Stomach & Intestinal (Other General, non-Endoscopic), Colorectal (Other General, non-Endoscopic), Liver (Other General, non-Endoscopic), Gallbladder & Biliary (Other General, non-Endoscopic), Pancreatic (Other General, non-Endoscopic), Other (Other General, non-Endoscopic).

Neuro, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Neurosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Neurosurgery Procedures Database covers major neurosurgical procedures, including: Surgeries for Traumatic Brain Injuries, Ventricular & Shunt Surgeries, New Shunt Placements, Revision Shunt Surgeries, Endoscopic Third Ventriculostomies, Diagnostic Ventricular Endoscopies, Vascular Lesion Procedures, Vascular Lesion Surgeries, Vascular Lesion Coil Procedures, Pituitary Tumor Surgeries, Open Pituitary Tumor Surgeries, Endoscopic Pituitary Tumor Surgeries, Intracranial Tumor Surgeries, Open Intracranial Tumor Surgeries, Endoscopic Intracranial Tumor Surgeries, Cranioplasties, Intracranial Neurostimulation and Peripheral Nerve Procedures, Intracranial Neurostimulator Implant Procedures, Peripheral Nerve Neurostimulation Procedures, Other Peripheral Nerve Procedures.

OB/GYN, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Obstetric and Gynecological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Obstetric and Gynecological Surgical Procedures Database covers major obstetric and gynecological procedures, including: Obstetrical Surgeries Cesarean Sections, Destructive Operations, Episiotomies, Other Obstetrical Surgeries, Gynecological Surgeries Colposcopies, Hysterectomies, Salpingo-Oophorectomies & Oophorectomies, Colposcopies, Salpingo-Oophorectomies & Oophorectomies, Hysterectomies, Total Hysterectomies, Subtotal Hysterectomies, Vaginal Hysterectomies, Breast Cancer Surgeries, Breast Reconstruction Surgeries, Breast-Conserving Surgeries, and Mastectomies, among other surgeries.

Ophthalmology, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ophthalmological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ophthalmological Surgical Procedures Database covers major ophthalmological procedures, including: Cataract Surgeries, Phacoemulsification Surgeries, ICCE Surgeries, ECCE Surgeries, MSICS Surgeries, Refractive Surgeries.

Orthopedic, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Orthopedic Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Orthopedic Surgical Procedures Database covers major orthopedic procedures, including: Hip Arthroplasties Revision Hip Arthroplasties, Hip Resurfacing Procedures, Primary Hip Arthroplasties - Total Hip, Partial Hip, Knee Arthroplasties Revision Knee Arthroplasties, Primary Knee Arthroplasties - Partial Knee, Primary Knee Arthroplasties - Total Knee, Extremity Fractures Using Hardware Extremity Fractures Using Hardware - Upper Extremities, Extremity Fractures Using Hardware - Fractures of the Femoral Neck & Shaft, Extremity Fractures Using Hardware - Other Lower Extremity, Arthroscopies Knees (Arthroscopies), Shoulders (Arthroscopies), Ankles (Arthroscopies), Feet & Toes (Arthroscopies), Others (Arthroscopies), Other Joint Arthroplasties Finger & Hand, Wrist, Elbow, Shoulder, Ankle & Foot.

Peripheral Vascular, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Peripheral Vascular Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Peripheral Vascular Surgeries Procedures Database covers major peripheral vascular procedures, including: Arterial Procedures Thrombectomies & Thromboendarterectomies, Carotid Artery Thrombectomies, Upper Limb Artery Thrombectomies, Iliac Artery Thrombectomies, Renal Artery Thrombectomies, Lower Limb Artery Thrombectomies, Arterial Angioplasties, Carotid Artery Angioplasties, Upper Limb Artery Angioplasties, Iliac Artery Angioplasties, Renal Artery Angioplasties, Lower Limb Artery Angioplasties, Arterial Bypasses, Carotid Artery Bypasses, Upper Limb Artery Bypasses, Iliac Artery Bypasses, Renal Artery Bypasses, Aortofemoral and Aortobifemoral Bypasses, Femoropopliteal Bypasses, Femorotibeal Bypasses, Other Lower Limb Bypasses, Venous Procedures Head, Neck, & Upper Limb Thrombectomies & Thromboendarterectomies of Dialysis Access Venous Segments, Thrombectomies & Thromboendarectomies of Other Upper Limb Veins, Angioplasties of Dialysis Access Venous Segments, Angioplasties of Head, Neck and Other Upper Limb Veins, Lower Limb Venous Procedures Removals of the Saphenous Vein, Removals of Other Veins of the Lower Limbs.

Spine, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spine Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Spine Surgical Procedures Database covers major spine procedures, including: Cervical Spine Surgeries Cervical Spine Decompressions, Cervical Spine Discectomies, Cervical Spine Fusions, Cervical Spine Disc Replacements, Thoracic and Deformity Procedures Thoracic Spine Decompressions, Thoracic Spine Discectomies, Thoracic Spine Fusions, Instrumented Procedures for Deformities, Lumbar Procedures Lumbar Spine Decompressions, Lumbar Spine Discectomies, Lumbar Spine Fusions, Insertion of Lumbar Interspinous Process Spacer, Lumbar Spine Disc Replacements, Vertebroplasties & Kyphoplasties Vertebroplasties, Kyphoplasties, Other Spine Surgeries.

SRS, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Stereotactic Radiosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Stereotactic Radiosurgery Procedures Database covers major stereotactic radiosurgery procedures, including: Intracranial SRS Procedures, Extracranial SRS Procedures, Extracranial Spine Procedures, Extracranial Lung Procedures, Other Extracranial Procedures.

Urological, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Urological Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Urological Surgeries Procedures Database covers major urological procedures, including: Kidney Stone Procedures Extra Corporeal Shock Wave Lithotripsy, Percutaneous Nephro Lithotripsy, Ureteroscopies, Open Kidney Stone Procedures, BPH Procedures Transurethral Prostatectomies, Other BPH Surgeries, Prostatectomies, Nephrectomies Partial Nephrectomies, Radical Nephrectomies, Bladder Procedures Therapeutic Endoscopies, Diagnostic Endoscopies, Urethral Catheterizations of Bladder.

Global Markets for Hip Replacement Implants, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for hip replacement implants. The market for hip replacement implants includes all prosthetic devices used to replace damaged sections of the hip joint, including those used in total and semi/hemi replacement procedures. This market snapshot is intended to provide a high-level overview of the global market for hip replacement implants, with key insights into: Procedure volumes from 2022 to 2028, Market forecasts from 2022 to 2028, Competitive landscape analysis of major competitors, Insights into key market events for strategics and startups. Companies covered in this report include: B. Braun, DePuy Synthes, DJO Global, Exactech, Johnson & Johnson, Medacta, MicroPort Scientific, Ortho Development, OSSIS, SERF SAS, Smith+Nephew, Symbios Orthopedie, Total Joint Orthopedics, Zimmer Biomet.

Global Markets for Peripheral Vascular Guidewires, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Atherectomy Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Electrosurgery, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Vascular Balloons & Vena Cava Filter, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for percutaneous transluminal angioplasty (PTA) balloons and inferior vena cava (IVC) filters. A PTA balloon is used in the treatment of peripheral artery disease (PAD) to open a narrowed or blocked artery. IVC filters are permanent or temporary devices to prevent the travel of thrombotic material to the lungs. These devices are frequently used in the management of patients with severe PAD. This market snapshot is intended to provide a high-level overview of the global market for PTA balloons and IVC filters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Acotec Scientific, Adient Medical, B. Braun, BD, Biotronik, Boston Scientific, Brosmed, Cagent Vascular, Cardinal Health, CONMED, Cook Medical, Concept Medical, Cordis, Covellus, Degania Medical, iVascular, Medtronic, Merit Medical, NextStep Medical, Nipro, OrbusNeich, Orchestra BioMed, Philips, Terumo, TriReme Medical.

Global Markets for Mechanical Heart Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Tissue Heart Valve Replacement, 2023-2028
Published:
2023
Next Update:
Q2 2030
Deliverables:
excel pdf

Description coming soon.

Global Markets for Transcatheter Mitral Valve Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Femoral Closure, 2023-2029
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for femoral closure devices. Femoral closure devices are used to achieve hemostasis of the hole in the artery that is created to perform catheter-based cardiovascular or endovascular procedures. This market snapshot is intended to provide a high-level overview of the global market for femoral closure devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Cardinal Health, Cardiva, Cordis, CyndRx, Endocor, Haemonetics, Morris Innovative, Rex Medical, Teleflex, Terumo, Transluminal Technologies, Vasorum, Vivasure Medical.

Global Markets for Tricuspid Valve Repair, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for tricuspid valve repair devices. Tricuspid valve repair is the preferred surgical approach for the treatment of degenerative tricuspid valve disease. The market is currently experiencing a renaissance with the introduction and development of transcatheter solutions for tricuspid valve repair and replacement. Devices covered within the scope of this analysis include tricuspid valve annuloplasty rings and transcatheter tricuspid valve repair devices. This market snapshot is intended to provide a high-level overview of the global market for tricuspid valve repair devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, CroiValve, Edwards Lifesciences, Innoventric, Medtronic, Mitral Holdco, Mitralix, NaviGate, OrbusNeich, TriCares, Venus Medtech.

Global Markets for Percutaneous Pulmonary Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement. This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Edwards Lifesciences, Medtronic, PolyVascular, Venus Medtech.

Global Markets for Coronary Angio Guidewires & Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for coronary angiography catheters and guidewires. These devices are essential to perform coronary angiography, a minimally invasive medical procedure used to visualize blood flow, identify blockages and narrowing of the coronary arteries. Devices covered within the scope of this analysis include coronary angiography catheters and coronary angiography guidewires. This market snapshot is intended to provide a high-level overview of the global market for coronary angiography catheters and guidewires, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AngioDynamics, B. Braun, Boston Scientific, Cardinal Health, Cook Medical, Cordis, Medtronic, Merit Medical, Philips, Teleflex, Terumo.

Global Markets for Oncology Ablation Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology ablation catheters. These devices are used as a therapeutic modality employing energy to selectively destroy cancerous tissue. Devices covered within the scope of this analysis include radiofrequency and microwave ablation electrodes, excluding cryoablation devices, which are covered in a separate report. The snapshot offers a high-level overview of the global market for oncology ablation catheters and guidewires, with key insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: AngioDynamics, Baylis, Boston Scientific, Canyon Medical, CAPS Medical, EDAP, Galvanize Therapeutics, Imagin Medical, Medtronic, Mermaid, Mirai Medical, Monteris, Sonablate, Stryker, TROD Medical, and US Medical Innovations.

Global Markets for ENT Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for endoscopic devices for ear, nose, and throat (ENT) surgery. These devices are used to examine and operate on the structures and tissues in the ear, nose, and throat. Devices covered within the scope of this analysis include ENT endoscopic surgical instruments, balloon sinus and dilation catheters, and rigid endoscopes and bronchoscopes. This market snapshot is intended to provide a high-level overview of the global market for ENT endoscopic surgery devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: 3NT Medical, Acclarent, Conmed, Endoluxe, Entellus Medical, Intuitive Surgical, Johnson & Johnson, KARL STORZ, Medtronic, Olympus, Pentax, Pristine Surgical, Richard Wolf, Smith & Nephew, Stryker, Tympany Medical.

Global Markets for Cell Delivery Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cell delivery catheters. These devices are primarily research-use devices for the delivery of cellular therapies for the treatment of chronic diseases, such as cardiovascular disease and cancer. Devices covered within the scope of this analysis include cell delivery catheters. This market snapshot is intended to provide a high-level overview of the global market for cell delivery catheters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: BioCardia, Biosense Webster, Boston Scientific, Cordis, Medtronic, Mercator MedSystems, TriSalus Life Sciences, TRI Medical.

Global Markets for Urology Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for urology and renal devices, focusing on treatments for six major conditions: End-stage renal disease (ESRD), Incontinence, Calculi (stones), Benign prostatic hyperplasia (BPH), Prostatitis, and Erectile dysfunction (ED). The devices covered within this analysis encompass a range of tools for diagnosis, treatment, and management, including urinary bags, foley catheters, catheter insertion kits, intermittent catheters, endourology devices, BPH ablation devices, lithotripsy devices, and artificial penis devices. The snapshot provides key insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: 3M, Applied Medical, Astratech, Balton, Baxter Healthcare, B. Braun, BD, Boston Scientific, Calyxo, Corinth Medtech, Coloplast, EndoMed, Flume Catheter Company, Hollister, ICU Medical, Karl Storz, Medline, Medtronic, Merit Medical, Nipro, Olympus, SonoMotion, Teleflex, and Urovision.

Global Markets for External Pain Pumps, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for external pain pumps. These devices are used to provide patients with consistent, long-lasting pain relief by delivering pain medication epidurally, intravenously, or subcutaneously. Devices covered within the scope of this analysis include external infusion pumps for pain management. This market snapshot is intended to provide a high-level overview of the global market for external pain pumps, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Avanos, B. Braun, BioQ Pharma, Epic Health, ICU Medical, InfuTronix, Medical Flow Systems, Medipacs, MicroPort, Smiths Medical, Teleflex.

Global Markets for Ureteral Access Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence delves into the global market for ureteral access devices, crucial components utilized alongside ureteroscopy or percutaneous nephrolithotomy procedures. These devices facilitate dilation and create a working channel for various urologic interventions. The snapshot aims to offer insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it provides a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Amecath, Applied Medical, BD, Boston Scientific, Cook Medical, Envaste, Johnson & Johnson, Mednova, Olympus, Richard Wolf, Rocamed, Teleflex, and Terumo.

Global Markets for Pelvic Floor Repair, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for pelvic floor repair mesh. These products are used during surgical procedures to repair prolapse and urinary incontinence. Devices covered within the scope of this analysis include pelvic floor repair/reconstruction mesh. This market snapshot is intended to provide a high-level overview of the global market for pelvic floor repair mesh, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: BD, Boston Scientific, Coloplast, Cook Medical, Ethicon, Johnson & Johnson.

Global Markets for Atrial Fibrillation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Neurovascular Devices Ischemic, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence analyzes the global market for devices used in the treatment of ischemic stroke, focusing on solutions designed to remove occlusions in blood vessels to prevent and treat this condition. The market snapshot offers insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Cerenovus, Ceretrieve, Cordis, InNeuroCo, Julier, Medtronic, MicroPort Scientific, Microvention, Penumbra, Phenox, Poseydon Medical, Route 92 Medical, Stryker, and Terumo.

Global Markets for Neuromodulation Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global neuromodulation market – a thriving market for managing and treating neurological diseases, chronic pain, and other chronic conditions. Types of neuromodulation, or neurostimulation, devices include implantable and transcutaneous devices, including wearable devices. This market snapshot is intended to provide a high-level overview of the global neuromodulation market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bionics, Alyve Medical, Axonics, Biotronik, Boston Scientific, EBT Medical, electroCore Medical, Inspire Medical, LivaNova, Medtronic, Neuromod Devices, Nevro.

Global Markets for Vertebroplasty Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vertebral augmentation products, which are crucial in treating vertebral compression fractures, often caused by osteoporosis or spinal tumors. Vertebroplasty and kyphoplasty are the primary surgical interventions, and the market includes products such as vertebroplasty and kyphoplasty cement, as well as delivery devices. The snapshot aims to provide a comprehensive overview of the global vertebral augmentation products market, with key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Halma, IZI Medical, Medtronic, Mendec, Merit Medical, RevBio, and Stryker.

Global Markets for TAVI/TAVR, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Drug Delivery, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Benign Prostation Hyperplasia Implants, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Butterly Medical, Endotherapeutics, Olympus, ProArc, ProVerum, Teleflex, Urotronic, ZenFlow.

Global Markets for Cryoablation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for cryoablation devices for non-cardiovascular applications. These devices are used to freeze and induce cellular damage and death for indications including cancer, dermatological conditions, peripheral vascular disease, and urological conditions. This market snapshot is intended to provide a high-level overview of the global cryoablation devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Boston Scientific, Brymill Cryogenics, Channel Medsystems, CooperSurgical, CPSI Biotech, CryoConcepts, CryoProbe, CryoSurgery, CSA Medical, Endocare, Endocision, Grand Cryo, Ictero Medical, KryoLife, Mectronic Medical, Sedivention, Siemens Healthineers, Varian Medical Systems, Wallach Surgical.

Global Markets for Diagnostic Electrophysiology Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for diagnostic electrophysiology catheters. These devices are used to measure and map electrical activity within the heart to identify aberrant electrical activity that causes arrhythmias. LSI projects that this market will remain in a high growth phase due to improving technology for the surgical treatment of cardiac arrhythmias and atrial fibrillation (AF). This market snapshot is intended to provide a high-level overview of the global diagnostic electrophysiology catheters market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AccuPulse, Acutus Medical, BD, Biosense Webster, Boston Scientific, CardioNXT, CoreMap, Johnson & Johnson, Kardium, Medtronic, MicroPort Scientific, Stereotaxis.

Global Markets for Hernia Repair, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence (LSI) provides an analysis of the global market for hernia mesh products for the surgical repair of hernias. The global market for hernia mesh products is projected to see moderate growth throughout the forecast period covered by the analysis. While the market has been negatively impacted by ongoing lawsuits associated with product complications, the next generation of products has helped the market to recover for one of the most performed abdominal surgeries. This market snapshot is intended to provide a high-level overview of the global market for hernia mesh products, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Allergan, Ariste Medical, BD, Cook Medical, Deep Blue Medical Advances, Ethicon, Exogenesis, Integra Lifesciences, Johnson & Johnson, LifeCell, Medtronic, Novus Scientific, Tarian Medical, TELA Bio, TISSIUM, W.L. Gore.

Global Markets for CRM Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure. This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AtaCor Medical, BioTrace Medical, Biotronik, Boston Scientific, Cairdac, Electroducer, FineHeart, Lepu Medical, LivaNova, Medico, Medtronic, Merit Medical, Microport Scientific, Osypka Medical, Pacetronix.

Global Markets for Neurovascular Devices Hemorrhagic, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for neurovascular devices for the treatment of hemorrhagic stroke. These solutions are used to treat intracerebral bleeds, ruptured aneurysms, and other neurovascular deformities that lead to the pooling of blood vessels that have ruptured inside and outside of the brain. This market snapshot is intended to provide a high-level overview of the global market for neurovascular devices for hemorrhagic stroke, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Acandis, Artio Medical, Endostream Medical, Medtronic, MicroPort Scientific, Microvention, Phenox, Penumbra, Rapid Medical, Shape Memory Medical, Stryker, Terumo, Wallaby Medical.

Global Markets for Renal Denervation, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for renal denervation devices for the treatment of refractory hypertension (i.e., high blood pressure that does not respond to pharmaceuticals). The market for renal denervation devices includes radiofrequency and ultrasound catheters which are used to ablate the renal nerves. This market snapshot is intended to provide a high-level overview of the global market for renal denervation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Ablative Solutions, Brattea, Medtronic, Metavention, Otsuka Medical, ReCor Medical, SoniVie.

Global Markets for Upper+Lower Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence analyzes the global market for suture anchors used in upper and lower extremity repair and reconstruction procedures. Suture anchors play a critical role in securing soft tissue to bone, particularly for severe soft tissue tears. The market encompasses bioabsorbable, biocomposite, metallic, and PEEK suture anchors. The snapshot aims to offer insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Acumed, Acuitive Technologies, aevumed, Anika Therapeutics, Arthrex, ConMed, DePuy Synthes, Johnson & Johnson, Mitek, OSSIO, Paragon 28, Responsive Arthroscopy, Riverpoint Medical, Smith & Nephew, Stryker, and Zimmer Biomet.

Global Markets for Peripheral Stents, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for biliary and peripheral vascular stents. These devices are used to maintain and restore patency to anatomical ducts or vessels that have become obstructed due to the formation of plaque, narrowing of the natural lumen, or presence of benign and malignant growths. This market snapshot is intended to provide a high-level overview of the global peripheral vascular and biliary stents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, BD, Biotronik, Boston Scientific, Bryan Medical, Cardinal Health, Cook Medical, Cordis, Endo GI Medical, Hood Labs, Maquet, Medtronic, Merit Medical, MicroPort Scientific, Olympus, Q3 Medical, Zorion Medical.

Global Markets for Electromagnetic Navigation Systems, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for electromagnetic navigation systems for tracking, guiding, and positioning instruments during surgery. These systems provide surgeons and the surgical team with real-time information on the position and orientation of instruments used during open and minimally invasive surgeries. This market snapshot is intended to provide a high-level overview of the global electromagnetic navigation systems market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Brainlab, Collin Medical, Elucent Medical, Fiagon, Heal Force, Joimax, Karl Storz, Medtronic, Olympus, Stryker, Veran Medical Technologies.

Global Markets for GI Endoscopy, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot report from Life Science Intelligence provides an analysis of the global market for gastrointestinal (GI) endoscopic devices. These devices are used to visualize, diagnose, and surgically treat conditions of the GI tract. The market for GI endoscopic devices includes endoscopes and endoscopic instruments. This market snapshot is intended to provide a high-level overview of the global market for GI endoscopic devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Ambu, Applied Medical, Aqua Medical, Aspero Medical, B. Braun, Boston Scientific, ConMed, Endoluxe, Ethicon, Integra Lifesciences, Intuitive Surgical, IQ Endoscopes, Johnson & Johnson, Karl Storz, Medtronic, MiWendo Solutions, Olympus, Purple Surgical, Richard Wolf, Stryker, Teleflex.

Global Markets for Hemodialysis, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for hemodialysis solutions. Hemodialysis is an essential treatment for patients suffering from end-stage renal disease due to kidney failure. Hemodialysis systems, catheters, and dialyzers are components integral to hemodialysis treatment. This market snapshot is intended to provide a high-level overview of the global hemodialysis solutions market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Asahei Kasei, AngioDynamics, B. Braun, Baxter, Bellco, Byonyks, Diality, Fresenius, Hemoclean, Humacyte, Intermedt, Inspira Health, iRen-MEDICAL, Medivators, Merit Medical, NextKidney, Nikkiso, Nipro, Rockwell Medical, Telelfex, Terumo, Toray Medical, TVA Medical, Vantive.

Globals Markets for Cardiac Ablation, 2023-2028
Published:
Next Update:
Deliverables:

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac ablation devices, which are used for the treatment of arrhythmic heart conditions, such as atrial fibrillation. The market for cardiac ablations devices is projected to see strong growth throughout the forecast period covered by this analysis, driven by demographic trends and the adoption of new technologies for the treatment of new ablation technologies, such as Pulsed Field Ablation. Devices covered within the scope of this analysis include cardiac ablation catheters. This market snapshot is intended to provide a high-level overview of the global market for cardiac ablation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Adagio Medical, AtriAN Medical, AtriCure, Biosense Webster, Boston Scientific, Electrophysiology Frontiers, Field Medical, Galvanize Therapeutics, Healium Medical, Johnson & Johnson, Medtronic, Stereotaxis.

Global Markets for Atrial Septal Occlusion, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for atrial septal occlusion devices. These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth. This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, atHeart Medical, Cardia, Hanyu Medical, Lifetech Scientific, Occlutech, W.L. Gore.

Global Markets for Aortic Grafts, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for aortic stent grafts for the treatment of aortic aneurysm. The market for aortic stent grafts includes open (surgical) and endovascular (transcatheter) aortic stent grafts used in the repair of abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). This market snapshot is intended to provide a high-level overview of the global market for aortic stent grafts, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Cook Medical, Endoron, Endospan, Lombard Medical, Medtronic, MicroPort Scientific, Taurus Vascular, Terumo, TripleMed, W.L. Gore.

Global Markets for Interventional Cardiology Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for interventional cardiology devices for the treatment of cardiovascular diseases such as heart failure or severe atherosclerosis. The market for interventional cardiology devices includes devices used to diagnose and treat diseases related to the coronary arteries. Devices included within the scope of this report include coronary stents, catheters, angioplasty balloons, guidewires, and intravascular ultrasound catheters. This market snapshot is intended to provide a high-level overview of the global market for interventional cardiology devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bifurcation Systems, B. Braun, BD, Boston Scientific, Cardinal Health, Cook Medical, Corflow Therapeutics, Fastwave Medical, Lemaitre Vascular, Medtronic, Merit Medical, MicroPort Scientific, NirvaMed, Philips, Teleflex, Terumo, Translumina.

Global Markets for Oncology Embolization, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization, and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death. This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: ABK Biomedical, Arsenal Medical, Boston Scientific, Cook, Cordis/Cardinal Health, Instylla, Medtronic, Merit Medical, Ned Medical, Obsidio, SirTex Medical, Stryker, Terumo, Varian.

Global Markets for Vascular Access Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vascular access devices, which are essential for continuous and long-term access to the bloodstream for administering intravenous drugs and fluids. The market encompasses various types of devices, including peripherally inserted central catheters (PICC), midline catheters, central venous catheters (CVC), and implantable ports. The snapshot aims to provide a comprehensive overview of the global market for vascular access devices, offering key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Access Vascular, AngioDynamics, B. Braun, Baxter, Becton, Dickinson & Company (BD), Bluegrass Vascular, C.R. Bard, Cook Medical, ICU Medical, Medline, Smiths Medical, Teleflex, Terumo, Vygon, and Yushin Medical.

Global Markets for Rotator Cuff Repair Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for rotator cuff repair suture anchors for the treatment of rotator cuff injuries. The market for rotator cuff repair suture anchors includes anchors composed of biocompatible polymers and metals. This market snapshot is intended to provide a high-level overview of the global market for rotator cuff repair suture anchors, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Aevumed, Arthrex, Atreon Orthopedics, ConMed, DePuy Synthes, Embody, Inovedis, Smith & Nephew, Stryker, Tetrous, Wright Medical, Zimmer Biomet.

Global Markets for Electrical Stimulation Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Wearable Monitoring Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Low Complexity Medical Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Canada Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Canada Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Canada. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Germany Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Germany Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Germany. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

France Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The France Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for France. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

U.K. Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United Kingdom Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United Kingdom. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Italy Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Italy Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Italy. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Spain Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spain Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Spain. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Poland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Poland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Poland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Netherlands Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Netherlands Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Netherlands. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Belgium Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Belgium Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Belgium. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Sweden Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Sweden Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Sweden. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Switzerland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Switzerland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Switzerland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Denmark Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Denmark Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Denmark. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Finland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Finland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Finland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Norway Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Norway Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Norway. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

China Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The China Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for China. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

India Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The India Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for India. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Japan Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Japan Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Japan. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Korea Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Korea Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Korea. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Australia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Australia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Australia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Thailand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Thailand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Thailand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Malaysia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Malaysia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Malaysia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Singapore Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Singapore Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Singapore. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

New Zealand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The New Zealand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for New Zealand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Caribbean Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Caribbean Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Caribbean region. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Argentina Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Argentina Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Argentina. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Colombia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Colombia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Colombia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Chile Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Chile Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Chile. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Guatemala Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Guatemala Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Guatemala. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Dominican Republic Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Dominican Republic Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Dominican Republic. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Costa Rica Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Costa Rica Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Costa Rica. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Panama Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Panama Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Panama. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Mexico Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Mexico Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Mexico. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Brazil Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Brazil Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Brazil. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Turkey Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Turkey Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Turkey. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Russia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Russia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Russia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Africa Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Africa Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Africa. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.
Schedule Meeting
Request Info
close
Video Transcription
close

Ed Muzio  0:05  
Well, hi everybody. Glad you're here. This has been a new topic, a new ish topic, I think, in this way, for LSI and where this came from, I'll tell you more about me. We get to intros, but just to kind of tee up what we're doing here, I was here last year. I did a panel with a CEO of RefleXion Medical, Todd Powell, and we talked about a culture change that I had done with him and his organization. And it was kind of like a LSI saying, Well, you know, will anyone come to this if they have other places to sit in the hall, you know? And they did. And so the feedback was positive enough that we decided this year to expand it to sort of this broader question of, hey, as you're growing in size, what can you look at and as your team gets bigger, and so I will tee it up in terms of group sizes, which Jeff and I were talking on the phone previously. And I picked the numbers based on what I know about how group work works. And he went those the same numbers I see based on how startups works. I think we got some pretty good so we're gonna start off small and kind of step up and just talk about each of our experiences in terms of what that looks like. I think I'm going to ask you to hold questions till the end, because I normally in a panel, I go whatever we talk about is fine, but we're trying to actually make an arc here from small to big. So we'll try and make that arc, and then leave some time at the end for discussion, and that'll be some questions we can do here in the room, and then we'll be here after as well. So that's kind of the the plan. And so with that, I think I'll move into intros, and I'll just let each of us kind of talk through kind of what our background is and how we care to be here. So Susan, you'll start, yeah,


Susan Insley  1:28  
sure. My name is Susan Insley, and I currently am not in your industry at all. I work for a company called nexnav. We IPO ed as a de SPAC. Recently, last couple of years, and we're about 100 people, and throughout my career, I've worked at different size companies, usually starting at the small but then getting to the really big and and I've, I'm here because of my HR experience, but I also kind of grew up in finance and internal audit, so I've, kind of, I've seen a lot. So 


Ed Muzio  2:01  
all right, Jeff


Jeff Pompeo  2:04  
Hi everybody. Appreciate you coming. My name is Jeff Pompeo. I'm the president, CEO and co founder of a company in Charlottesville, Virginia, called Caretaker Medical. We make a wireless wearable patient monitor that measures continuous beat by beat, blood pressure, cardiac output, stroke volume, advanced hemodynamics and fluid response as a noninvasive alternative to invasive. A lines and Pa catheters in high risk patients across the full continuum of care. Data goes to the cloud and so forth and so on. We're commercial phase. 18 months ago, got our FDA clearance last year did sort of our soft launch, and this is the year we're hitting the gas pedal and really going direct sales to hospitals. I guess my timing could have been better with hospitals budgets being tight and slashed in the environment we're in. But you know, it's all about reducing costs and improving patient outcomes, and maybe most importantly, improving productivity for clinicians inside the hospital. So, background, yeah, so, so I started in giant organizations. I'm an ex GE guy, so I was GE with GE for many years, running large businesses, and that was back in the Jack Welch era, where, you know, if those of you remember him, he was just maniacal about people. The you know, the company was the people, the products were second, and managing those people and driving them, and driving the culture and stack ranking them, and, you know, constantly turning your bottom 10% you know, those were core tenets. And to make a long story really short, so I left ge 21 years ago to do my first startup. This is my fifth startup. We've been lucky enough to monetize and exit the other four, two in medical devices, two in technologies. And I think you know, when Ed we're talking the interesting thing was that transition from running these giant, well oiled everything is a template organization to making it up in my basement with two other people was a incredible transition. And my wife says it's a disease that I have now this entrepreneurship thing, I can never go. It's funny, our last company that we exited, I had to, I called it the indentured servitude year. You know, when you get acquired, you have to work for a year for the I couldn't stand it. I mean, it was just nothing against the company, just the big corporate bureaucracy, I learned, is just not in my DNA. So it's the quick, nimble, make mistakes, fast, back the truck up and try again. That I really


Ed Muzio  4:44  
love I've got that resonates for me. So sorry my my background is big Corp to small as well. So I started day to 10 years in tech. I worked for Intel. Intel's having a hard time right now. I worked for Intel nerd really well. And I I got into, I was engineer, and I got into kind of how system. Work and how authority works and how decisions get made. And then 10 years after I started, I exited. I've been doing this for 20 years, and this is really working with companies. And now I work from Fortune 500 all the way down to start up with 50 people, 20 people, and it's the same work. What I'm doing is I'm saying we have 70 years of research and experience that says that if you work the way most companies work, you get what most companies get, which starts with meetings, where you get together and everyone talks for nine minutes each about how it's going, and the answer is mostly well. And then they run around do a bunch of work, so they can say mostly well next week. And so you get late, if any warning that things are off track, and the top performing companies don't do that, they get together and they go, we're going this way, and in the future. And right now, it looks like we're headed here. So let's do this today to put that back together. And then we do that, and it breaks something. And so we go do something to fix that. And so I call it iterate. My book out there is iterate. And you just the company claws its way through. And so I always say, What I know is two things, what has to happen. I wrote that in the book, and how to get it to happen. And I do that by coming in and working for about a quarter with leadership to just run the company that way. Because if you just ask people to do it, and you go, all you go, all you got to do is stick your neck out and say, something's wrong. Who wants to go first? Right? And the answer is, maybe they do. So we do it all at once around the company. We speed up right away. And so that's kind of my background here. But I was resonating with what you said, because I work fortune 500 and I work startup, and I can work a fortune 500 and they will say to me, we cannot believe the progress you made in a quarter and how much faster we are. And I smile and go, I'm glad you were happy. And I go home and go, because when I work in a 50 person or 100 person or a 300 person company, like, we change what the company is like, and it's different. Forever. I'm gone and it's different. So it's really, I think I'm unemployable now, like, even, but it's really kind of fun to watch the same thing. You're the small company now, like, you see it, like it's there. So, so anyway, let's, let's start small. We're gonna, we're gonna move, like, from five to really big, and we're gonna start with five to 15. So, you know, five is, everyone fits around a table. This was my bias. And picking these numbers, right? They're just representative, but everyone fit around a table. And then we get to 15, which is, like, we still fit around a table, but it's a big table, and it's a little harder to have a conversation like we used to have. And also there's probably, you know, at five, the mission was probably like, make a thing, and at 15, now there's probably something else, commercial, financial, there's more stuff coming in. So it's also more complex, right? So why don't you start us off? Jeff, what? What do you see at five and 15 that has to happen, you know? How do you set up for the next


Jeff Pompeo  7:20  
phase? Yeah, and there, it's interesting, you know, back to that, when I left GE to go to this first startup, I was sort of the number two guy in the startup, and there were six of us, and I kept trying to institutionalize and templatize and and formalize everything. And, you know, I'll go back to his name was also Ed, just sort of my mentor at that time that taught me how to be an entrepreneur. Was, you break all that, right? This is about to your point, iteration. It's try, try, try, faster, faster, faster. So, so for us as that company, we grew that company from the six of us that started it to about 120 people in about two years. And that was, that was the classic late 90s, you know, you could get funding on a PowerPoint. You know, you get $20 million on the PowerPoint from Sand Hill Road and run with it. And so it was about spend as fast as you can, so that you can, you know, quickly raise another round with an up round. But the cultural we hired, we hired so fast. And so that culture, we spent creating the company for those first five or six, or the six of us together, we all knew everything about everything. There was unequivocal trust. I mean, you know, we vacation together. I mean, it was like a family, right? We our kids knew each other. We had dinners together. And as we started adding people, there was a there was a time where we were hiring three or four people a day, especially out in this in the sales team that was and we had to learn how to delegate. We had to learn how to empower and trust, but have a feedback mechanism, mechanism where you could quickly, quickly ascertain where that trust wasn't working or that trust was being taken advantage of, so that you could clip it, and that got me back to my Jack Welch training is you can't be afraid to terminate someone fast and early when it's clearly not working since fast, which


Ed Muzio  9:11  
is not that hard to do at 15, but it's not that easy. Oh,


Jeff Pompeo  9:15  
yeah, one of those other core tenants was you're going to spend 80% of your time trying to turn a C player into a B player, when you should be spending 80% of your time on your a player, finding an a plan. And that's what we kept trying to judge, so that that that scale was fast and rapid, and it broke all our processes. I mean, we we had to go from running a company with spreadsheets to buying a system and implementing a system. And I remember when we when we got to about 20 people, that's when we hired our first HR person, right? Which was a godsend, because we, you know, we were all trying to do HR on the side, if you will, right, while doing our real jobs, and it wasn't or that that's fine at five, seven, maybe even 10, that's


Ed Muzio  9:59  
recover. Yeah, but then, yeah, yeah, no, that's great, I think. And I'm, by the way, as a side note here, I'm panelist and moderators. We decided we'd rotate who talks when, so I'm going to jump in here if we go along. But I, for me, somebody asked me today for a podcast interview, like, what can you do when you're five? Because, of course, I have this whole book that's really about levels, and my first answer is, right at five. At three, it doesn't work, but right at five, start making decisions together in a way that is the way we know works to make decisions, and that is, we know who the decider is, and the decider listens to everything everybody knows, and then the decider says, here's what I'm deciding, and here's why. And then everybody does that thing. And I say that, it sounds very obvious, but it's very easy to tip into something like voting. It won't be called voting at five. You won't say, let's take a poll. But people say things like, let's see how everybody is leaning. And anything that looks like voting, this is not a political comment. This is a group work and business comment, anything that looks like voting in small group work produces irrational results. And the reason is, if we three work for the same boss, and the boss says, twice in a row, let's see how you're leaning. We have a future together, and we have a history together, and we like each other, or we don't. And so we are going to start trading votes. And so that person immediately is removed from information, because now I don't come in and go, here's what I know. And Jeff says, Here he knows. Susan says, Here's what I know. We say, we all agree, Boss, do this because I've horse traded for something else later. And so start small. Do that. As you move 15, you can start to say, Okay, now let's bring in a future look. Let's make sure we're continuing to look down the road, because at five, you will automatically look forward. At 15, you will start doing the status update dance. Here's what's going on today, so make sure you're not doing that. Do the what's coming in six months, what's coming a year? What can we do today about the future? Because you can just say this, if you're in the company, we cannot do anything today about what's done, right? So let's make a decision. Let's start now making decisions for the future. And if we have a one hour meeting and we're 23 minutes in and we haven't made a decision yet, let's fix that meeting. So we stopped doing that. If you catch that at 15, yeah, it'll save you a lot. Yeah. I


Susan Insley  11:57  
want to go back to something Jeff said about hiring. I think one of the things that's really important at this phase is really understanding who's on the team and what they can do, so making sure you understand who are your utility players and who are your experts. And then that's going to also come into play when you're talking about making decisions, like, who do you know that you need to ask more questions to so that you're getting the best information out on the table, and you can be the decider, or whoever is the decider, but you've got to think about that team as a portfolio of assets. And as you start to grow, you need to know where your gaps are and where you're going and what you're going to need in order to get there, so that having that inventory at the ready is it's going to be super important. 


Ed Muzio  12:41  
And I think you start that early and start to build it started early. 


Susan Insley  12:44  
So then as you're hiring, either going to 15 or 15 and beyond, you're you're filling in your portfolio,


Ed Muzio  12:51  
right, right, right, yeah, I feel like both of us have had individual version of this conversation where it's like, don't get the big bureaucratic template yet, yeah, but think ahead, just a little just just a little bit of prep for that, which it's understandably hard to do,


Susan Insley  13:06  
yeah, yeah. And this is the time too, to really solidify that trust. So both of you talked about trust, so I agree it's not voting, but making sure that everybody has the opportunity to put information out on the table, and you're listening. As a really key part of building.


Ed Muzio  13:23  
Don't skip the listening. Yeah. 


Susan Insley  13:25  
Don't just go straight to, like, ask questions, be curious, listen to the answers, and then decide, yeah for sure. 


Ed Muzio  13:29  
And there is a thing there that I think actually has a good launch into our next size, which is okay, so now we're going from 15 to 25 right? So now, and you kind of noticed into this a little bit, Jeff in your conversation already, but, like, conversation already. But like, you know, from my perspective, 15 we could get around a table. 25 I mean, I guess we could find a table, but I can't hear that person anymore. So we're not only at a place where we can't do group work, we're also at a place now where, like, we can't even really have a conversation. All we can do is someone can give a presentation, and people can go like this, right, which is not actually decision making. So, you know, same questions, you know, what do we do? And I think that the thing that I would add to kind of key into what you guys just said is, I'll go first on this one, is I talked about already look forward. Now you've basically started to say, hey, we have 25 people. So you guys go work and come back and so, so now we get into look up, which is when I send someone off to do something, whether it's them by themselves, or them with a group they're running. I need to make them understand, yeah, you have a goal, but we're not holding you accountable to your goal. We're holding you accountable to owning a piece of the higher level goal, right? So you can't succeed at your piece. This is not that hard to do at 25 this is exceedingly difficult to do at 100 because everyone goes, here's my status, boss, and it looks, looking good, right? So, but, but if you can get to this place you go, no, no, you we may change your goal at a time. We're all doing this together. We succeed or fail together. If you can start to plug that in at that 2025, space that, I think is that is the piece that helps you together with that is we want bad news. I have stickers on my table and say, We love reality. At 25 you have to start to say, Bring me bad news. Bad news is good news because that's the place where it also tips into, Oh, my boss's boss wants to hear that it's going well, so let's make it look like it's going well, like no, my boss's boss wants to hear what's broken. We solve the biggest problem every week. And so you have to learn my favorite thing to tell leaders as I go practice, saying this the way you see me arranging my face, is worry about what's coming up, but not about you personally. Thank you for bringing the problem. Please continue to bring problems, because otherwise they go, Oh, he's mad. I'll never bring another problem, right? So that's the, that's the that's my thing for for 2550 to 25 to start. Susan, how about you?


Susan Insley  15:41  
Yeah, I think just building on that, not not taking any of that, this is the time where you're really starting to establish culture in your company, so you have trust with the small group around the table. And now you're going to expand the table, so you're, you're not necessarily going to be connecting with everyone in the same way you were connecting with that smaller group a year previously, or what have you. So your trust is going to come into play. You're going to start needing to put a little bit of structure in place so that communication and information still flows freely, that there's a place to bring the bad news, whether it's in you know a regular rhythm of one on ones, or just knowing people knowing that you have an open door so they can get to you with that bad news. Or daily stand up like this is the time to start creating a little bit more clarity about how information is going to move. Yeah, yeah,


Jeff Pompeo  16:36  
yeah. Right now we're, we're approaching the 20 person. So we're living this now, and you know, we've got a plaque in our conference room that says we attack ideas, not each other. I love that. And every Monday morning we have a stand up. And you know, the tenant of that whole stand up is, what are you afraid of? What are you worried about? You know, we were looking for the bad news, because as you grow to your point, that the bad news starts to get masked. Because now it's not a dozen people all you know with the same shared vision. Now it's you know, 2030, people that now career aspirations come in, and promotions come in, and layers and and all that that starts to mask the truth that as a CEO in particular, you got to know now, because as a small, perpetually underfunded company. You've got to see these problems coming. You know when they're small, because when they get big, it can be too late. The last point I made you mentioned utility players. I think that's another big inflection point when you're in that kind of 510, maybe 15, utility players are awesome, right? I want all Derek jeters, because they can play any position on the field any but then you get to 2025, now you got to start special you can't if you had all utility players. Now you have to start using process instead of people to solve these scale problems. And you can't just keep plugging in more shortstops. You've got to have a first baseman. That's great. And yeah. Then then you pepper in sort of the different profiles of the employees, right? How? You know, it never stops to I keep getting surprised over and over, which means I'm an idiot about this. But the way engineers, software, hardware engineers and scientists think is polar opposite to the way commercial and sales people think, you know, you know, engineers and tech, foot people, Aaron, something. It's the thrill of the chase, right? It's you do some, you do some vision casting of the CEO as the CEO. They're all in, and you're chasing that vision. And that's the goal, the satisfaction. I don't want to say sales people are coin operated machines, but to some degree, there's a little bit of that, right? And it's vision casting is not enough. There needs to be justification and answers and compensation programs that you know are more financially motivated in the short term, as opposed to just accomplishing the vision. So being aware of that as you grow and scale, especially in Medtech, because we all start basically with technical people first, then you grow to the commercial people, and you got to understand they're wired differently. They need to be managed differently. They're motivated differently. Not every employee is the same.


Susan Insley  19:13  
Yeah, just to add on to that, and I'm sorry to interrupt you, Ed, but like, I think that's a super important point. You're still at a size where you can make sure you have those individual connections and understand everyone's motivations and making sure you have the incentives and systems in place to keep those people motivated as they become further away from you in the daily activities. Right? If you're


Ed Muzio  19:37  
Right, you're at a size there where it's it takes a little more effort, but you still do it. Can still do it, 


Susan Insley  19:40  
Yeah, 


Ed Muzio  19:41  
Yeah. And that's, that's a good tee up for, okay, now we're gonna go from 25 to and I wrote in my notes 50 to 100 or more, which are really, really different and also kind of the same. It's kind of like if I give a keynote, and, you know, if I have 12 people or 20 people, I can tell, but if I have 300 or 500 people, like it's just me and bright lights and two rows, and it doesn't, it's. Like you lose that visibility, right? I think that's what happens. You know, now you've got now your meetings are happening in parallel, your mission and your issues are split into different pieces. So if you're the leader, you've got things happening that you don't need to know about. To your point, we start with highly technical people that are generalists and good at everything. And about 25 they can still run around and be in everything. They look pretty haggard, their hair doesn't look great, but they're in everything, right? And I've done many clients where I can point to the guy, it's usually the engineering manager, and go, that's the one. He's in all of it. But 75 people, that person cannot that's not sustainable anymore. You can't pack them all in room and have them go around and get updates. And so you've got to really, you've got to really start to figure out, what do you do about some two, you know, two levels away from me, and like, all of a sudden the important work is happening two levels away from me. So what does that mean? So who started Susan?


Susan Insley  20:46  
I'll take that one first. I think this is, I'm the culture person. So this is a really great time to start getting very clear on what your values are as an organization. So you don't want a lot of structure, but you do want to know from everyone in the organization, like, what are those kind of key tenants that everybody can operate off of and not have to be managed day to day? And so they know, like, our values are accountability or transparency, communication, whatever those are, and those are the things that they're going to use every day to guide their work, whether you're right next to them or not. So this is one of the things that I just did, coming into next nav, you know, 100 people was really helped them. I, you know, craft their identity, if you will, as a culture. So, you know, having all the employees kind of give us what are the top five things that you think that represent how we get work done. And then we did it kind of a tops down, bottoms up, kind of exercise, and realized that, hey, like, of all the words that were submitted, it was very clear that these five words here are the ones that everybody's using to get their work done, to make decisions, to guide their behaviors. And it was very easy for us to say, This is who we are and this is how we operate.


Jeff Pompeo  22:08  
Yeah, yeah. At that level, I think you know when you're small kind of sub, that when you start trying to stack Rike employees and all that, it's, it's, it's pretty obvious in a small organization, and who's great and who's not so great. Everyone knows that. You don't have to formal. You get to scale, 50 100 people. It becomes more ambiguous. You know, who's great? 


Ed Muzio  22:31  
What do you mean by great? 


Jeff Pompeo  22:33  
Yeah, what does great even mean?


Susan Insley  22:34  
 you don't see their work. So how do you know they're great? 


Jeff Pompeo  22:37  
Yeah. And, you know, we all try all the standard techniques, right? The skip level meetings, but, but to your point, Ed, skip level meetings, you don't always get authenticity in those conversations, right? It's career management kind of conversation, so you have to dig deep. And for me, it's, it's asking, you know, very specific questions, you know, let, let's go out into the factory floor. Tell me about this machine. Why this? Why that? To try to dig into to get past sort of the superficial fluff of, you know, all the boss is here. Let's put on a show, right? You know, you're not there for a show. You're there to understand the problems, right? It's all about solving these problems quickly, yeah, and then you're trying to maintain that culture. It's all about communication, right? If you don't. So, you know, I think now that we have zoom and all these tools that we didn't have a decade ago. It's much easier to have these all employee meetings and quick 30 minute bursts so you get face time with everybody. Everyone feels like a cohesive group, even as 100 it's really tough to do without putting a whole bunch of layers in between, which, yeah, is no good for anybody,


Susan Insley  23:39  
and the complexity of in person versus remote as well. So we have so many people on the workforce today who prefer to be remote. So we were talking about that last night. Jeff, maybe you want to talk a little bit more about that, because I think it was really important. 


Jeff Pompeo  23:53  
Yeah. I mean, if there's one good thing that came out of COVID, I would say it was this forcing function of embracing remote work, yeah. And it works, as long as the culture embraces, if there's this undertone of, we've got the, you know, we've got the in office people and the out off office people, I think that tips over pretty quickly. I don't think it works. 


Ed Muzio  24:15  
The other thing that I've seen is it drives a level of discipline. So I'm like, as you hear me talk, I'm very much about, how do we get together make decisions? And one of the things I saw when companies jump into Zoom is it's like you can fix a lot of badness in your meetings, in the hallway when you leave, so you can have a performative status, non decision oriented meeting. And everybody's walking out, they do the real work on Zoom. They all hit the red button and no work happens, right? They do the performance, and they go back to, like, being alone. So it does drive a level, I think, of discipline, both in how you approach it, like you're saying, and also, then, what do you do with the time you have together? Because it's necessarily limited,


Jeff Pompeo  24:45  
yeah, and we use Slack. I mean, there's a lot of tools like that, but that has helped, I think, with those hallway water stations. Yeah, you know, you're just always now, our software guys in particular say that's a very disruptive tool. I'm trying so. So we have sort of 'no Slack' period from twelve to two 


Ed Muzio  25:04  
Don't walk into my office. Yeah, yeah, exactly No. And I think, I mean, I think you are talking about the same stuff I always think about, which is, you know, from my perspective, like I have mostly leaders who are really good leaders who mean, well, like the nature of what I do is, let's be collaborative. So the ones that want to be dictators and really mean people, they walk away from me, which is lovely side effect of my career. But having said that, I work with these people that are really good leaders, and I don't think they always realize they're scary. They're not scary personality wise. They're not scary as people. But when you're my boss's boss or my boss's boss's boss, like, there's reptile brain stuff going on there. And so if you go, Great, let's have a skip level. What's going on. Like, you didn't say only bring me good news, but they heard it. And so I think, to your point, like, Go show me what's going on. I also think there's a very heavy modeling function. So I always tell my senior team, like, what's a bigger company? Like, I want you to run your meeting like, the way I'm talking about, like, forward looking. I want you to solve issues. I want you to reinforce the importance of bringing bad news. I also want you to get in the habit of when issues on the table and you can't solve it today and it doesn't need solution today. Have a mechanism where you go, you, you, you, you have two weeks go off, come back with recommendations I'm putting on the agenda now for two weeks, we'll ratify it. So there's a mechanism, because the better you model that in the senior team, the more it's going to copy down every every team on the way down is a bad photocopy. And so if you do those things loosely on the senior team, you're into a mess down there. Review it really well on the senior team, you'll get enough of it at the lower levels so that you have it happen. Because you can't go down there and tell them to do it without seeming like now you're that mean boss again. And I think if you, if you do that and get in the habit of showing them, hey, look, we listen, we act, we adjust, right? No news is, you know, no news is bad news, but bad news is good news, and no decision is final, but every decision is always implemented. I think that modeling at the top will flow down and make your culture too. 


Susan Insley  26:47  
Yeah, the modeling thing is really key, good and bad. So everyone needs to be very conscientious. If somebody does come and give you bad news, make sure it's not the person that you're getting ready to fire, because as soon as you terminate that person, everyone's going to know I brought them bad news, and they were the first out the door. So really, if you are going to be thinking about letting people go or making changes, I would be very conscientious about how you're communicating with that person what they're bringing to you. How do you make sure that it isn't tied to something that they've put on the table? 


Jeff Pompeo  27:25  
Yeah, and I think establishing that accountability structure as you scale and grow is critically important. And to your point, it's modeled at the leadership right? If you don't follow up on things, people get that and then they they won't follow. So yeah, we have a formal problem. We call it the FUP file, F-U-P, follow up. So there is a physical FUP file with all, I want to be very clear and enunciate that it's the FUP file. And that's become a cultural thing is, you know, where's the FUP on that? It's, you know, there's some


Ed Muzio  27:57  
very block and tackle stuff. I get into a senior people, and I never lead with this, because they'll think he's a meetings guy. And I meetings guy, and I'm not, but it's like agenda horizon, which is when you send the task force off to go come back with a recommendation, you put it on the agenda in two weeks now, that way it doesn't get forgotten about. You know, FUP, right? Like, what's so and so said they do this. And then people ask me, Well, how often should we review it? And I go, I don't know, review it some. And if people aren't doing stuff, review it more, they have a second year of time less. But like, have it, you know, and, oh, by the way, also, like, have a plan for the meeting. We're going to talk about this issue and this issue so that you're not walking in going, you know, what are we doing today? Because I've seen a lot of meetings where it's like, what are we going to talk about in staff today? You know, you better find something. It's like, No, you should have a queue of issues to do.


Susan Insley  28:37  
I just, I have this vision of people walking around the hall, going, what the FUP 


Ed Muzio  28:41  
what the FUP? What's on the FUP? Slack me the FUP. So we're good. I wanted to give us about 10 ish minutes for Q A, which we actually have. So any like, final thoughts before we jump into open Q A, and if you have a question, please kind of head for the microphone so they can get it on the recording, or, I guess we can. They'll bring it to you or something. But yeah, what any final thoughts? 


Susan Insley  28:59  
Well, I think we've got a question. I heard you're on the story. 


Audience Question  29:00  
So my question is about the application of this in the med tech context. So I've worked in 200,000 person companies. I currently lead a five person company, so have seen lots of different models, but one of the things in how fundraising trends have changed is there's more and more of us here at this conference who are getting into later stages of quality controls, right? You're at a QMS level where you have to have SOPs and you have to have control processes. Meanwhile, your team is still in that five to 10 category. And so can you just speak a little bit to how you think about the culture that's being less structured and less formalized, while at the same time having product activity and operational activity that does have to be more structured and formalized. How do you balance those two in smaller teams?


Jeff Pompeo  29:53  
I can take that. That's a phenomenal question, right? How do you maintain this fail fast? Entrepreneur, nobody. Bureaucracy in an environment, in a regulated FDA, regulated environment where you have to have a QMS platform. You know, I've done a number of these startups, so I make a different mistake in every one. Two startups ago, the mistake we didn't take QMS seriously. I mean, we had a three ring binder with paper SOPs that we downloaded from the Internet, and no one ever opened the book. That was a huge mistake, because when it came time for our audit, you know, guess what happened? So, so now we know we take QMS seriously. It's a semi automated process. We still take shortcuts, but we take them purposely, knowing we've got to go back and clean it up and we treat them as experiments. So the shortcut around this SOP or we're not putting, you know, this is going to happen outside the QMS system as an experiment on bench top or whatever. Then we'll go back and sort of do it again, Fast Track under the QMS rules and get it documented. 


Audience Question  30:58  
So I'm actually asking question the other way around. So as the company gets more and more controlled, how do you still keep a lot of the benefits of only a five to 10 person team having that much more informal communication and kind of without the QMS B and B production level, product considering 


Ed Muzio  31:21  
I can maybe talk to that a little bit and tell me if I'm getting it or not, but what I've seen in my clients, and this is from med tech and elsewhere as well, is V and V and product development life cycle and QMS stuff. All of that often gets confused with how we run the company. That's not how we run the company, that's an output that we carry. And so I had one client in Medtech who we did this intervention. Thing that I do, we put the iterate methodology in place, and on the QMS side, they're very clear to delineate, like, how we run meetings is not QMS. QMS is we decide in these meetings how to implement this thing. And so we've activated the, for want of a better term, the group intelligence, the organization, to keep clawing forward. And one of the outputs we carry is to have compliance, and is to have, you know, whatever we need in those ways. And we pay attention to the right thing. So we notice is our PLC, you know, serving us anymore, not because, you know, just like your filing system when you were 20s to now, it's like, it was great till I got my second job. And it's like, oh, that's not working, right? I need three folders now. Now now I need 100 levels, right? So, but as long as we task the human intelligence with keeping that up, instead of getting confused and saying, Oh, we use that as a way to regulate everything we do, that's what I've seen to work. Is that closer to what you're asking?


Audience Question  32:35  
Yeah, I just, I've seen this kind of tension. So thank you,


Audience Question 2  32:39  
Susan, you use the word, but I think in a different context, transparency, yes, and I've been part of four startups now, and one of which was bought in the middle of.com into his massive company in all the earlier ones, and I was a co founder in one of them, transparency was we shared Everything with everybody about the state of the company, the P and L on a quarterly basis. You know, things that are going well, things are going bad, and that's different than just being open communication, right, about getting your work done. So what's, what's your all thoughts on that? Because when we hit the big.com company, they're like, you can't tell all the employees that we're you know that that's inappropriate, that you're talking about that in meetings, and people started quitting because they just it's too ambiguous where we work, and we don't know what's going on.


Susan Insley  33:31  
Interesting, I think. You know, as a public company there, obviously there are things that you can't share and until you're in certain windows and, and in some cases, are things that just stay at the top and and can't go down. But I think it's really about what you think people need to know in order to really be invested in their work, right? So what? What helps them stay attached to the company? What builds trust with you and the other leaders. So are you sharing you ask them to share bad news. Are they? Are you sharing bad news with them too? So are you providing that level of vulnerability to create the trust that keeps the information flowing? So that's really the objective, if you will, of transparency. It doesn't necessarily mean everybody needs to know all the worst news that's going on, but enough to know that you you care about their level of commitment to the company so much so that you're going to bring them in. It's building inclusive culture, right?


Ed Muzio  34:38  
There's an active decision there about what can we not share? What must we share? And what's in the gray area? And I think that you know better, decision making at the top helps with that. I've seen a version of that too, where the you know, I do my thing, and at some point, and this has happened with most startup CEOs, they look at me and they go, I'm gonna know a lot more about kind of what's happening and what's in trouble now. And I go, Yeah. And they go, should I tell the board? Yeah? And I go, I don't know. I mean, yes sometimes. And so they all come to their own kind of peaceful place of like, what's an on stage conversation and what's a backstage conversation? Because these are forecasts, right? So, you know, like, what makes you more predictable to the board? And it's a version the same question, which is, what do I have to tell them? What should I never tell them? And then what's gray area and what's the benefit? So it's a conscious decision, I think, more than one answer, yeah, 


Jeff Pompeo  35:24  
Yeah, one cautionary tale. I mean, it's a bit situational to know who you're speaking to. I mean, yeah, if you're too transparent, you just terrify people, especially, especially as a negative EBITDA company, you know, that's trying to, you know, you're going to run out of money at some time. That terrifies people, right? Is it 12 months? Is it 12 months? Is it 18 months? Oh my gosh. Do I need to look?


Ed Muzio  35:44  
 There's no right answer. 


Susan Insley  35:45  
You don't need to keep reminding them. You need them to be focused on doing their work, right?


Jeff Pompeo  35:48  
Yeah, yeah. So there is some limit to, you know, just know your audience, I guess is the message, yeah.


Audience Question 3  35:55  
So we are currently living in the remote world where we see very good things happening, also, like sometimes a few positions works out very well with remote and few not, in my opinion, like to hear your thoughts, you thought of it. How is the future going to look like, especially having the culture of remote scaling up, having the remote positions, especially in the Medtech if you can.


Ed Muzio  36:22  
90 seconds future remote go.


Jeff Pompeo  36:24  
You have to embrace it. It's here to stay, and you're not going to get the best, best and brightest people if you mandate in the office. Generally, there are certainly exceptions. So you have to embrace it,


Susan Insley  36:35  
and you have to be intentional to make it successful in your company. And you can't just let it happen. As we have already mentioned. You've got to have communication mechanisms. You've got to have that trust in there so everybody's showing up at meetings. You've got to have a way to have Hallway Conversations, if you will, outside of meetings. So it does take a little bit of effort in it, but Jeff's right, it's not going away. So embrace it. 


Ed Muzio  37:00  
Last thing I can add to that is I have various clients at different with different approaches, and if you have some people remote and some people in a room, invest in the software that puts cameras in the room so when they can see who's talking. So it's not like a little square with nine little heads, because that makes it a lot better. It's almost like the same experience. We are out of time. Thank you for being here. We'll hang a bit for discussion afterwards, I'll head down to my table where I have books come and get one. They're heavy, and I don't wanna take them home. But 


Susan Insley  37:00  
and free 


Ed Muzio  37:00  
and free, thank you. Heavy and free, that's the sales pitch. But thanks for being here, thanks for attending, and please stick around and chat with us after.


Susan Insley  37:33  
Thanks everybody.


Ed Muzio  37:35  
Thank you.